TCL Archive NCI disclosure of walk-out by Data and Safety Monitoring Board of the National Lung Screening Trial may be harmful, improper, experts say. April 16, 2004
TCL Archive FDA Proposes “Clarification” Of Clinical Studies regulations, Including Sanctions, Inspections August 18, 1978
TCL Archive NCI’s use of Cancer Dialogue for biospecimen network blueprint raises legal, procedural questions. December 12, 2003
